共 74 条
- [1] McLaughlin SA(1991)NIH consensus conference. Treatment of early-stage breast cancer JAMA. 265 391-395
- [2] Wright MJ(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet. 365 1687-1717
- [3] Morris KT(2008)Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements J Clin Oncol. 26 5213-5219
- [4] Grube BJ(2001)Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial Semin Surg Oncol. 20 230-237
- [5] Giuliano AE(2010)Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg. 252 426-432
- [6] Giuliano AE(2011)Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA. 305 569-575
- [7] McCall L(2007)Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea: a report from the Korean Breast Cancer Society J Clin Oncol. 25 2360-2368
- [8] Beitsch P(2005)Nationwide cancer incidence in Korea, 1999–2001; first result using the national cancer incidence database Cancer Res Treat. 37 325-331
- [9] Giuliano AE(2010)Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean Breast Cancer Society J Clin Oncol. 28 1692-1699
- [10] Hunt KK(2011)Less may be better: axillary dissection is unnecessary in some patients with a positive sentinel lymph node Arch Surg. 146 980-982